Annual Shareholders Equity
$230.76 M
-$42.13 M-15.44%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual stockholders equity is $230.76 million, with the most recent change of -$42.13 million (-15.44%) on December 31, 2023.
- During the last 3 years, SPRY annual shareholders equity has risen by +$244.81 million (+1742.19%).
- SPRY annual shareholders equity is now -15.44% below its all-time high of $272.89 million, reached on December 31, 2022.
Performance
SPRY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$200.98 M
-$14.26 M-6.63%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly stockholders equity is $200.98 million, with the most recent change of -$14.26 million (-6.63%) on September 30, 2024.
- Over the past year, SPRY quarterly shareholders equity has dropped by -$14.26 million (-6.63%).
- SPRY quarterly shareholders equity is now -26.35% below its all-time high of $272.89 million, reached on December 31, 2022.
Performance
SPRY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SPRY Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.4% | -6.6% |
| 3 y3 years | +1742.2% | -6.6% |
| 5 y5 years | +1742.2% | -6.6% |
SPRY Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.4% | +838.0% | -26.4% | +556.4% |
| 5 y | 5-year | -15.4% | +838.0% | -26.4% | +556.4% |
| alltime | all time | -15.4% | +838.0% | -26.4% | +556.4% |
ARS Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $200.98 M(-6.6%) |
| Jun 2024 | - | $215.24 M(-3.9%) |
| Mar 2024 | - | $223.87 M(-3.0%) |
| Dec 2023 | $230.76 M | $230.76 M(-2.7%) |
| Sep 2023 | - | $237.28 M(-4.5%) |
| Jun 2023 | - | $248.55 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $261.15 M(-4.3%) |
| Dec 2022 | $272.89 M(-972.7%) | $272.89 M(-719.7%) |
| Jun 2022 | - | -$44.03 M(+40.8%) |
| Dec 2021 | -$31.27 M(+122.5%) | - |
| Dec 2021 | - | -$31.27 M |
| Dec 2020 | -$14.05 M | - |
FAQ
- What is ARS Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual shareholders equity year-on-year change?
- What is ARS Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly shareholders equity year-on-year change?
What is ARS Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of SPRY is $230.76 M
What is the all time high annual shareholders equity for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual stockholders equity is $272.89 M
What is ARS Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, SPRY annual stockholders equity has changed by -$42.13 M (-15.44%)
What is ARS Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of SPRY is $200.98 M
What is the all time high quarterly shareholders equity for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly stockholders equity is $272.89 M
What is ARS Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, SPRY quarterly stockholders equity has changed by -$14.26 M (-6.63%)